Endometriosis and adenomyosis compared

Endometriosis and adenomyosis are different conditions that can occur together and can be associated with overlapping concerns, including pelvic pain and fertility difficulties. The clearest anatomical distinction is location: endometriosis involves endometrial-like tissue outside the uterus, while adenomyosis involves tissue within the uterine muscle. That distinction is useful, but it does not assign every symptom to one condition or predict an individual's course. Comparing them requires separating anatomy, symptoms, methods of assessment, and the outcomes measured in research. ^[1][2][3]

The anatomical distinction

Endometriosis is defined by tissue resembling the uterine lining occurring outside the uterus. Adenomyosis is defined by endometrial glands and supporting tissue within the muscular uterine wall. The names refer to different locations and disease processes. Neither definition is a severity ranking. The endometriosis and adenomyosis guidelines address distinct diagnostic and management questions, even though some of the same symptom concerns appear in both. ^[1][2][3]

The table is a comparison of definitions and evidence scope, rather than a diagnostic checklist. A symptom does not identify the location of tissue by itself. The integrated adenomyosis review specifically describes symptoms as heterogeneous and poorly specific, while the endometriosis guideline describes variable presentations. That shared variability is one reason the anatomical distinction must remain separate from interpretation of a person's symptoms. ^[1][3]

Similar symptoms do not make the conditions identical

The European endometriosis guideline identifies pain and infertility as major concerns. The Canadian adenomyosis guideline considers heavy menstrual bleeding, different forms of pelvic pain, and reproductive outcomes. These categories overlap, but they are not interchangeable endpoints. A study about bleeding has asked a different question from a study about a pain measure, and a study about a clinical pregnancy has asked a different question again. ^[1][2]

That distinction prevents a misleading comparison such as deciding which condition is “worse” from one outcome. The experience of pain, the burden of bleeding, and reproductive goals do not share a universal unit of measurement in these guidelines. They are addressed through different clinical questions. A comparison becomes more useful when it identifies the concern being considered instead of trying to rank two disease names as if one necessarily implies a greater burden. ^[1][2]

Symptoms also do not establish which condition is responsible when several findings coexist. The adenomyosis review describes overlap with endometriosis and fibroids, while noting that some people with adenomyosis are asymptomatic. That means finding adenomyosis and explaining every symptom are separate interpretive steps. The same care is needed before assigning all pelvic pain to a known endometriosis diagnosis. The chronic pelvic-pain bulletin explicitly considers pain not fully explained by identified pathology. ^[3][15]

Coexistence is a research question in its own right

A systematic review examined endometriosis and adenomyosis together rather than assuming that evidence about each separately explained the combined situation. It compared fertility and pregnancy outcomes across groups with neither condition, one condition, or both. This design recognizes that coexistence may matter, while leaving open how much of any observed difference is explained by the conditions themselves or by other characteristics of the studied groups. ^[13]

The review reported lower clinical pregnancy and live-birth outcomes in the captured literature for comorbid disease, but findings for several obstetric outcomes were inconsistent. The distinction between a consistent direction for one endpoint and mixed findings for another is important. It would be inaccurate to compress the entire review into a claim that every reproductive outcome is worse by a known amount. The authors themselves described a reproductive burden that remains incompletely understood. ^[13]

A health-system study of adenomyosis also documented coexisting diagnosis codes for endometriosis and fibroids. That is useful evidence about recorded care, but it is not the same as systematically imaging or operating on every member of the population to establish both conditions. Different study designs can each support coexistence as relevant while producing estimates that should remain attached to their own definitions and ascertainment methods. ^[14]

Why the evidence populations differ

Adenomyosis research has historically relied heavily on uteri examined after hysterectomy. An epidemiology review explains that this creates selection problems for estimates of frequency and risk factors. People whose tissue is available after surgery do not represent everyone who may have the condition. That history is especially important when a claim about a “typical patient” is based on a surgical series rather than a broader population. ^[4]

Endometriosis diagnostic studies can also involve selected populations. One prospective ultrasound study included 125 people with suspected endometriosis who then underwent laparoscopy. The pathway provided a surgical reference for checking imaging, but it also defined who entered the study. Results from that group cannot automatically be transferred to people having a routine pelvic scan, people with different symptoms, or people who do not undergo surgery. ^[8]

Selection is therefore a shared issue, even when the selection pathways differ. A head-to-head adenomyosis imaging review used hysterectomy pathology as its reference standard. The endometriosis study used laparoscopic and histopathological findings. Both designs answer useful diagnostic questions, but neither supplies an unselected picture of everyone with pelvic symptoms. A fair comparison preserves these differences instead of placing their accuracy numbers side by side as though the studies had enrolled equivalent groups. ^[6][8]

What ultrasound is looking for in endometriosis

The endometriosis ultrasound consensus from the Society of Radiologists in Ultrasound proposes additions to routine pelvic assessment. It discusses observations of the posterior compartment, relative positioning of the uterus and ovaries, and the uterine sliding sign. The panel's concern was that endometriosis may not be appreciated on routine imaging beyond a visible endometrioma. These recommendations concern a focused set of observations, rather than a universal claim that all pelvic scans already assess the same targets. ^[9]

The prospective ultrasound study reinforces why the target matters. It found substantially stronger detection for ovarian and deep endometriosis than for superficial disease in its study setting. A negative observation about one category therefore cannot be silently expanded to cover every category. The relevant question is which finding was sought and how that search was performed, rather than whether “ultrasound” in the abstract is a good or bad test. ^[8]

These findings also distinguish an expert consensus from a performance study. The consensus defines an approach intended to improve assessment and reporting. The prospective study measures diagnostic performance under specified conditions. Agreement about technique and evidence about accuracy contribute different information. Keeping those roles separate avoids treating the existence of a recommended protocol as proof that it is uniformly available, uniformly performed, or guaranteed to settle a case. ^[8][9]

What ultrasound is looking for in adenomyosis

The revised MUSA consensus describes direct and indirect features of adenomyosis in the uterine muscle. Direct features include myometrial cysts, bright tissue islands, and echogenic lines or buds extending beneath the lining. Indirect features include changes such as a globular uterus, asymmetrical wall thickening, fan-shaped shadowing, and an irregular or interrupted junctional zone. These observations concern the uterus itself, a different anatomical target from many endometriosis-focused observations. ^[5]

The direct-versus-indirect distinction is a reporting distinction. It does not make every feature equally conclusive or create a validated score for pain. The panel used a modified Delphi process to clarify definitions, with experts reviewing images and working toward consensus. This can improve communication about appearances while leaving questions about prognosis and treatment response to other kinds of research. A carefully named feature is still an observation requiring interpretation. ^[5]

Thus, an ultrasound that comments on the uterine muscle and an ultrasound that maps deep endometriosis may contain different information even when both are called a pelvic ultrasound. Their reports should be compared in terms of actual observations. The endometriosis consensus and MUSA consensus address different targets, so neither framework should be assumed to stand in for the other. An educational comparison cannot infer from the test's name alone which assessments were completed. ^[5][9]

MRI and ultrasound comparisons need context

A systematic review compared MRI and transvaginal ultrasound for adenomyosis in six studies involving 595 women who received both examinations. It found similar pooled performance, with no statistically significant difference between the modalities. However, heterogeneity was high, and half of the included studies had high risk of bias in patient selection. The conclusion concerns those studies and their reference standard, rather than a universal rule that one test always replaces the other. ^[6]

The same caution applies when comparing that review with a routine-report study. The latter found that adenomyosis was detected less accurately in ordinary clinical reports than might be expected from focused research assessments. Directed reevaluation of MRI improved accuracy within its dataset. This shows why “what does the technology permit?” and “what did this report assess?” are different questions. The difference can matter without implying that every routine report is unreliable. ^[7]

The useful comparison is therefore not a competition between two machine names. It is a comparison of the anatomical target, examination protocol, reporting method, study population, and reference standard. Those elements determine what an accuracy estimate describes. Leaving them out creates false precision: a percentage may still look exact while its relevance to the question at hand has become unclear. The adenomyosis review and routine-report study illustrate different parts of that problem. ^[6][7]

A map of findings is not a map of experience

Adenomyosis classification research distinguishes disease mapping from a system that reliably links imaging or histological categories with symptoms, mechanisms, or outcomes. Mapping describes distribution. A predictive classification would need evidence that a category forecasts something important in clinical care. The review identifies substantial uncertainty about definitions and classifications, including disagreement around some histological thresholds. A descriptive label should therefore not be promoted into an individual prognosis. ^[10]

A similar distinction is useful when reading endometriosis imaging research. The prospective study separated superficial, ovarian, and deep findings because their detection differed. Those categories were part of its diagnostic question, not a ranking of how much pain a participant ought to experience. Its accuracy results cannot assign an acceptable level of disruption to someone with a particular finding. They describe agreement between imaging and the study's reference observations. ^[8]

Keeping these distinctions visible protects the meaning of both the symptom account and the anatomical account. A detailed scan can supply information without replacing the person's report of function. A substantial symptom burden can remain important without identifying a unique structural source. The chronic pelvic-pain bulletin addresses pain not fully explained by identified pathology and describes multidisciplinary care as one way to address its complexity. ^[15]

Biological hypotheses remain different from established causes

A review of adenomyosis mechanisms presents several theories about tissue appearing in the uterine muscle. These include changes at the boundary between lining and muscle, cellular transformation, movement of cells from outside the uterus, and hormonal or developmental influences. The authors emphasize uncertainty about the underlying processes. Listing theories is a way to describe active investigation; it is not evidence that all of them occur in every person or that one has been established as the sole cause. ^[11]

Endometriosis genetics research provides another type of biological evidence. A large association study identified multiple genetic regions associated with the condition and shared genetic patterns with some pain and inflammatory conditions. It studied groups and associations, rather than offering a test that explains an individual's symptoms. The included ancestry groups and disease categories are part of its scope. These findings cannot be substituted for clinical assessment or used to infer that a single genetic mechanism accounts for all pelvic pain. ^[16]

The comparison is useful because it separates three levels of explanation: what defines a condition, what mechanisms researchers propose, and what an investigation has actually measured. An anatomical definition can be clear while causal pathways remain uncertain. A biological association can be robust within a study without becoming a personal prediction. Neither uncertainty nor growing mechanistic knowledge erases the need to evaluate symptoms and findings in their clinical context. ^[3][11][16]

Fertility outcomes need their own labels

A meta-analysis of adenomyosis included 17 observational studies and reported associations with lower clinical pregnancy rates after assisted reproductive treatment and with some adverse pregnancy outcomes. These are group-level findings. They do not establish that everyone with adenomyosis will have difficulty conceiving or that the condition alone caused every observed difference. The study design, comparison groups, and adjustment methods remain essential to interpreting the result. ^[12]

The coexistence review asked a different question: how outcomes compared when endometriosis and adenomyosis occurred together. It reported results separately for clinical pregnancy, live birth, and several pregnancy complications. Some findings were inconsistent. Combining every endpoint into the phrase “fertility problems” would discard information the review preserved. Clinical pregnancy and live birth are different outcomes, and pregnancy complications concern a further set of questions. ^[13]

The endometriosis and adenomyosis guidelines both discuss reproductive care, but neither makes fertility the only relevant concern. A person may be seeking help for pain or bleeding rather than pregnancy. Evidence becomes more useful when its endpoint matches the question being discussed. A finding about pregnancy rates is not a direct measure of pain relief, and a symptom improvement is not evidence of improved reproductive outcome unless that outcome was actually studied. ^[1][2]

Treatment categories do not determine personal choices

The endometriosis guideline considers medical, surgical, and other approaches across several clinical questions. The adenomyosis guideline also describes medical, interventional, and surgical options, with attention to symptoms and reproductive goals. Similar broad category names do not mean that an intervention has the same evidence, purpose, or consequences for both conditions. The anatomical target and the measured endpoint remain part of every treatment question. ^[1][2]

A list of options also does not establish their order for a particular person. The endometriosis guideline acknowledges areas where the evidence cannot identify a most appropriate approach, while adenomyosis guidance emphasizes tailoring management to concerns such as bleeding, pain, and fertility. An article comparing disease names cannot resolve the individual factors needed for those choices. Its role is to clarify what a study or guideline is addressing, without recommending a treatment or implying a guaranteed result. ^[1][2]

This is especially important when more than one condition is documented. Evidence for an intervention in one condition cannot simply be assumed to explain outcomes in a comorbid population. The coexistence review exists precisely because combined disease raises a separate research question. A careful care discussion can keep the target of an intervention explicit and leave other unresolved concerns visible, rather than treating one label or procedure as an answer to every symptom. ^[13]

Comparing two reports without creating a false contradiction

An illustrative pair of records might include a uterine-muscle finding on one examination and no ovarian endometrioma on another. Those statements concern different structures and targets. They are not, through their wording alone, contradictory conclusions about the same condition. The anatomical definitions and the differing imaging frameworks explain why the exact observation matters more than a broad shorthand such as “positive scan” or “negative scan.” This example does not interpret a real medical record. ^[3][5][8][9]

Another record might preserve ongoing pain alongside an inconclusive explanation. The chronic pelvic-pain bulletin recognizes care needs beyond pain fully explained by identifiable pathology. Keeping the symptom question open is therefore compatible with documenting the current limits of an investigation. It does not prove that either endometriosis or adenomyosis is present. It also does not turn an incomplete structural explanation into a judgment about the legitimacy of the experience. ^[15]

Coexisting codes are not a population screening estimate

In the health-system adenomyosis study, 18.0% of the diagnosed group had an endometriosis code and 47.6% had a fibroid code. Those figures describe recorded coexistence within that study. They should not be presented as the chance that any reader with one condition has another. The investigators studied an insured population, identified diagnoses from administrative codes, and validated a subset by reviewing medical records. Each step affects what the resulting numbers represent. ^[14]

The same study reported a 78.5% positive predictive value for its adenomyosis coding approach among potential cases with sufficient chart information. That validation result shows why a large database and a confirmed clinical cohort are different research resources. Administrative data can reveal patterns at a scale that would be difficult through individual examinations, but the case definition retains uncertainty. More participants do not remove a limitation in how cases were identified. ^[14]

The epidemiology review adds the complementary caution that specimen-based research selects people through surgery. Neither a coded cohort nor a pathology series is automatically the right denominator for every public-facing claim. A comparison of endometriosis and adenomyosis is more accurate when it names the source of its counts and leaves the boundary of inference intact. ^[4]

What this does not tell you

This comparison cannot diagnose either condition, interpret a personal report, determine the cause of a symptom, or recommend imaging, medication, or surgery. The cited sources include guidelines, expert consensus, selected diagnostic studies, observational research, and systematic reviews. Their findings apply to defined questions and populations, with different limitations. Reading them together improves context; it does not create a validated diagnostic rule or a personalized risk estimate. ^{[1][2][5][6][8][12]}

It also cannot make one condition exclude the other, make normal imaging exclude all causes of pain, or turn a descriptive imaging category into a forecast. Coexistence research, detection differences, and classification uncertainty all argue for retaining those boundaries. The practical goal of the comparison is a clearer account of what each term means and what each piece of evidence can contribute, while leaving clinical interpretation and individual decisions to the patient and care team. ^{[8][10][13][15]}